| FLEXOPHARM GmbH & Co. KG was founded in August 2007.
FLEXOPHARM makes the highest quality medicinal products available to the healthcare system at the lowest possible
costs. To achieve this, it has dispensed with distribution costs entirely and keeps administrative costs extremely
low.
FLEXOPHARM carries out the activities necessary to obtain licenses and marketing authorizations for generics
The dermatologist Dr. Ulrich Matthes is the Managing Director and sole shareholder of the
company.
|
He serves at the same time as Managing Director of the companies PPM-Medical Holding GmbH, PHADIMED GmbH & Co. KG and PHAMETRA GmbH. From 1995 to 2007 Dr. Matthes was also Managing Director of FUMEDICA GmbH in Germany and Poland.
In addition to organizing and carrying out the market launch of Omeprazole FLEXOPHARM 20 mg and 40 mg, FLEXOPHARM is working to achieve licenses and market authorizations for additional medicinal products covering a broad range of
indications.
A Scientific Advisory Council has been set up at FLEXOPHARM to safeguard the company's high quality
standards.
|
